Faculté de Médecine Pierre et Marie Curie and Department of Radiology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
Hepatology Department, Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, French Network for Rare Liver Diseases in Adults and Children (FILFOIE), Saint-Antoine Hospital, Assistance Publique - Hôpitaux de Paris (APHP), INSERM, UMR_S 938, CDR Saint-Antoine, UPMC Univ Paris 06, Paris, France.
Eur Radiol. 2019 Mar;29(3):1460-1468. doi: 10.1007/s00330-018-5697-3. Epub 2018 Aug 29.
To evaluate the prognostic value of cystic dilatation (CD) of the intrahepatic biliary ducts in patients with primary sclerosing cholangitis (PSC).
A single-center cohort of 205 patients with PSC from 2003 to 2016 was analysed. CD was defined by quantitative and qualitative criteria. Radiological and clinical courses were assessed. A Kaplan-Meier analysis was used to estimate cumulative survival without liver transplantation (LT) from the date of PSC diagnosis. A log-rank test was performed to compare survival time of PSC patients with and without CD.
A total of 15 (7.3%) PSC patients (12 males) with a median age of 23 years at diagnosis had CD. Five patients had one CD; seven patients had two or three CDs; and three patients had diffuse CD. CDs ranged in small diameter size from 12 to 32 mm. Radiological evolution of CD was markedly variable. However, a radiological worsening of PSC over time was observed in all patients. The clinical course was characterized by the occurrence of complications in most patients. Half of the patients with CD underwent LT at a median time of 40 months from diagnosis of CD and the median survival time from PSC diagnosis was significantly lower than in PSC without CD (10.7 vs. 23.4 years; HR 3.8, 95% confidence interval: 1.7-8.3, p = 0.001).
CD in PSC is an unusual condition that mostly affects young patients. It is characterized by a rapid, unfavorable course and constitutes a significant prognostic factor.
• Cystic dilatation of the intrahepatic biliary ducts affects young patients with primary sclerosing cholangitis and is characterized by a markedly variable radiological evolution. • Biliary wall inflammation, found in explanted livers, could be a key feature in the pathogenesis of cystic dilatation. • Cystic dilatation of the intrahepatic biliary ducts is characterized by an unfavorable course and constitutes a significant prognostic factor of primary sclerosing cholangitis.
评估原发性硬化性胆管炎(PSC)患者肝内胆管囊性扩张(CD)的预后价值。
对 2003 年至 2016 年期间在单一中心接受治疗的 205 例 PSC 患者进行分析。根据定量和定性标准定义 CD。评估放射学和临床病程。使用 Kaplan-Meier 分析从 PSC 诊断日期估计无肝移植(LT)的累积生存率。采用对数秩检验比较有和无 CD 的 PSC 患者的生存时间。
共有 15 例(7.3%)PSC 患者(12 名男性)在诊断时的中位年龄为 23 岁存在 CD。5 例患者有 1 个 CD;7 例患者有 2 个或 3 个 CD;3 例患者有弥漫性 CD。CD 的直径大小从 12 到 32mm 不等。CD 的放射学演变差异很大。然而,所有患者的 PSC 都随时间出现了恶化。大多数患者的临床病程都伴有并发症。一半的 CD 患者在诊断为 CD 后中位时间 40 个月进行了 LT,从 PSC 诊断开始的中位生存时间明显低于无 CD 的 PSC(10.7 与 23.4 年;HR3.8,95%置信区间:1.7-8.3,p=0.001)。
PSC 中的 CD 是一种罕见的疾病,主要影响年轻患者。它具有快速、不利的病程,是一个重要的预后因素。
• 肝内胆管囊性扩张影响年轻的原发性硬化性胆管炎患者,其放射学演变差异很大。
• 在肝移植标本中发现的胆管壁炎症可能是胆管囊性扩张发病机制的关键特征。
• 肝内胆管囊性扩张具有不利的病程,是原发性硬化性胆管炎的重要预后因素。